Safety and Technical Performance of Plastalgin and Plastalgin Fast in Patients Requiring a Dental Impression

April 21, 2023 updated by: Septodont

Prospective, Multicenter, Observational cLinical triAl Measuring Safety and Technical Performance of plAstalgin and Plastalgin Fast in Patients Requiring a Dental Impression

The aim of this study is to gather clinical data related to the use of Plastalgin and Plastalgin Fast, in order to comply with the new medical device regulation. The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults.

Collection, recording, and reporting of data will be accurate and will ensure the privacy, health, and welfare of participating patients during and after the study

Study Overview

Study Type

Observational

Enrollment (Actual)

59

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montigny-le-Bretonneux, France, 78180
        • Cabinet dentaire
      • Paris, France, 75011
        • Cabinet dentaire

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults.

Minors are eligible to participate in the study. Other vulnerable patients can be included in the study as there is no additional risk for this population.

Description

Inclusion Criteria:

  • Patient fulfilling all the following criteria is eligible for the clinical investigation:
  • Male or female patient ≥ 5 years of age.
  • Indication of dental impressions for the fabrication of prosthesis such as mouth guards and trays, total or partial dentures, and fixed prosthesis (crowns, bridges, dental veneers).
  • Total or partially edentulous patient or patient with disocclusion or patient with misalignment.
  • Patient affiliated or beneficiary of a social security system.
  • Written informed consent must be obtained before any study-related assessment is performed.

Exclusion Criteria:

  • The presence of any of the following exclusion criteria will lead to the exclusion of the patient:
  • Inability to comply with study procedures.
  • Patient opposing the processing of their data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anatomical reproductibility of the dental impression with Plastalgin and Plastalgin Fast.
Time Frame: Immediately after the procedure.
Dentist's opinion through a questionnaire completed by the dentist
Immediately after the procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of impressions needed per patient
Time Frame: Immediately after the procedure.
Number of impressions needed per patient to make a quality impression.
Immediately after the procedure.
Setting time of Plastalgin and Plastalgin Fast
Time Frame: During the procedure.
Measure of the setting time by the dentist at each use of Plastalgin and Plastalgin Fast
During the procedure.
Rate of adverse events
Time Frame: During and immediately after the procedure.
Cumulative number of adverse events and serious adverse events
During and immediately after the procedure.
Rate of device-related adverse event
Time Frame: During and immediately after the procedure.
Cumulative number of adverse events and serious adverse events related to Plastalgin or Plastalgin Fast
During and immediately after the procedure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Stephanie INDUNI, MD, Cabinet dentaire

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2022

Primary Completion (Actual)

March 7, 2023

Study Completion (Actual)

March 7, 2023

Study Registration Dates

First Submitted

October 24, 2022

First Submitted That Met QC Criteria

November 5, 2022

First Posted (Actual)

November 14, 2022

Study Record Updates

Last Update Posted (Actual)

April 24, 2023

Last Update Submitted That Met QC Criteria

April 21, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • PLAS 2022-02
  • 2022-A00882-41 (Other Identifier: BRC Identification number)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Malocclusion

Clinical Trials on Plastalgin and Plastalgin Fast

Subscribe